CircR-FGFR1 sponges miR-381-3p to up-regulate the expression of CXCR4, thereby decreasing the number and activity of CD8+ T cells, and promoting tumor immune suppression and resistance to anti-PD-1 inhibitors [135]. The gene discussed is CD8A; the disease is neoplasm.